Despite advances in the management of venous thromboembolism (VTE), treatment of many
patients worldwide, especially in Asia, remains inadequate and/or discordant with prevailing …

Parenteral anticoagulation followed by warfarin has been conventionally used for the
treatment of venous thromboembolism (VTE). However, there are numerous troublesome …

Venous thromboembolism (VTE), which includes pulmonary embolism and deep vein
thrombosis, is a condition characterized by abnormal blood clot formation in the pulmonary …

Venous thromboembolism (VTE), manifesting as either deep vein thrombosis or pulmonary
embolism, is common worldwide including in Japan. The number of patients clinically …

Pulmonary embolism (PE) is the principal preventable cause of in-hospital deaths.
Prevalence of PE in Asians is uncertain but undoubtedly underestimated. Asians and …

Venous thromboembolism (VTE) is a spectrum of diseases that includes deep vein
thrombosis (DVT) and pulmonary embolism (PE). Anticoagulant treatment is the mainstay of …

When used in fixed doses for the treatment of venous thromboembolism (VTE) in patients
with or without cancer, direct oral anticoagulants (DOACs) have improved risk–benefit …

Background Several novel oral anticoagulants have been studied for the prevention and
treatment of venous thromboembolism (VTE) in different patient populations. Clinicians will …

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary
embolism, represents a significant source of morbidity and mortality. It is readily diagnosed …

Although the incidence of venous thromboembolism (VTE) in Asian populations is lower
than in Western countries, the overall burden of VTE in Asia has been considerably …